Single Particle Analyzer for High-Throughput and High-Content Characterization of Nanoparticle-Based RNA Therapy
Obtaining extensive in- and at-line input and output analytics combined with machine learning to improve predictive CQA
Automation and Control of a Precipitation-based Continuous Downstream Process for High Titer Products
Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies
